SElncRNAs in Cancer: Classification, Subcellular Localisation, Function and Corresponding TFs DOI Creative Commons

Yuxin Bao,

Songling Teng,

Hao Zhai

и другие.

Journal of Cellular and Molecular Medicine, Год журнала: 2024, Номер 28(24)

Опубликована: Дек. 1, 2024

ABSTRACT Emerging evidence highlights certain long noncoding RNAs (lncRNAs) transcribed from or interacting with super‐enhancer (SE) regulatory elements. These lncRNAs, known as SE‐lncRNAs, are strongly linked to cancer and regulate progression through multiple interactions downstream targets. The expression of SE‐lncRNAs is controlled by various transcription factors (TFs), dysregulation these TFs can contribute development. In this review, we discuss the characteristics, classification subcellular distribution summarise role key in regulation SE‐lncRNAs. Moreover, examine distinct functions potential mechanisms progression.

Язык: Английский

The emerging significance of the METTL family as m6A-modified RNA methyltransferases in head and neck cancer DOI
Ming Yang,

Zile Zhang,

Hao Qin

и другие.

Cellular Signalling, Год журнала: 2025, Номер unknown, С. 111798 - 111798

Опубликована: Апрель 1, 2025

Язык: Английский

Процитировано

0

Biological roles of enhancer RNA m6A modification and its implications in cancer DOI Creative Commons
Yangyang Han,

Jingqi Sun,

Minghui Yao

и другие.

Cell Communication and Signaling, Год журнала: 2025, Номер 23(1)

Опубликована: Май 30, 2025

Enhancers, as distal cis-regulatory elements in the genome, have a pivotal influence on orchestrating precise gene expression. Enhancer RNAs (eRNAs), transcribed from active enhancer regions, are increasingly recognized key regulators of transcription. N6-methyladenosine (m6A), most plentiful internal modification eukaryotic mRNAs, has garnered significant research interest recent years. With advancements high-throughput sequencing technologies, it been established that m6A modifications also present eRNAs. An accumulative body evidence demonstrates aberrant enhancers, eRNAs, and intimately connected with carcinoma onset, progression, invasion, metastasis, treatment response, drug resistance, prognosis. However, underlying molecular mechanisms governing eRNAs cancer remain elusive. Here, we review synthesize current understanding regulatory roles cancer. Furthermore, investigate possible tumorigenesis based existing literature, offering novel perspectives directions for future epigenetic cells.

Язык: Английский

Процитировано

0

RNA N6-Methyladenosine Modification in DNA Damage Response and Cancer Radiotherapy DOI Open Access
Cui Wang,

Shibo Yao,

Tinghui Zhang

и другие.

Опубликована: Янв. 12, 2024

N6-methyladenosine (M6A) modification is the most abundant internal chemical on RNA molecules in eukaryotes and can affect mRNA metabolism regulate transcription, nuclear export, splicing, degradation, translation, ets, has a significant impact various aspects of physiology or pathobiology. Radiotherapy common measure tumor treatment, variety cellular intrinsic mechanisms responses cells to ionizing radiation (IR) effectiveness cancer radiotherapy. In this review, we summarize discuss recent advances about roles M6A methylation radiation-induced DNA damage response, outcomes Insights into biology may facilitate improvement therapeutic strategies for radiotherapy as well radioprotection normal tissues.

Язык: Английский

Процитировано

2

Pathogenic role of super-enhancers as potential therapeutic targets in lung cancer DOI Creative Commons
Zhiyuan Yao, Peng Song, Wenjie Jiao

и другие.

Frontiers in Pharmacology, Год журнала: 2024, Номер 15

Опубликована: Апрель 12, 2024

Lung cancer is still one of the deadliest malignancies today, and most patients with advanced lung pass away from disease progression that uncontrollable by medications. Super-enhancers (SEs) are large clusters enhancers in genome’s non-coding sequences actively trigger transcription. Although SEs have just been identified over past 10 years, their intricate structure crucial role determining cell identity promoting tumorigenesis increasingly coming to light. Here, we review structural composition SEs, auto-regulatory circuits, control mechanisms downstream genes pathways, characterization subgroups classified according cancer. Additionally, discuss therapeutic targets, several small-molecule inhibitors, available treatment options for Combination therapies demonstrated considerable advantages preclinical models, anticipate these drugs will soon enter clinical studies benefit patients.

Язык: Английский

Процитировано

2

Targeting UBE2T suppresses breast cancer stemness through CBX6-mediated transcriptional repression of SOX2 and NANOG DOI
Keshen Wang,

Qichen He,

Xiangyan Jiang

и другие.

Cancer Letters, Год журнала: 2024, Номер 611, С. 217409 - 217409

Опубликована: Дек. 21, 2024

Язык: Английский

Процитировано

2

A Mutation Losing an RBP‐Binding Site in the LncRNA NORSF Transcript Influences Granulosa Cell Apoptosis and Sow Fertility DOI Creative Commons
Miaomiao Wang,

Wenmin Sheng,

Jiyu Zhang

и другие.

Advanced Science, Год журнала: 2024, Номер 11(40)

Опубликована: Авг. 9, 2024

Abstract Sow fertility is an economically important quantitative trait. Hundreds of trait loci (QTLs) containing tens thousands potential candidate genes are excavated. However, among these genes, non‐coding RNAs including long (lncRNAs) often overlooked. Here, it reported that NORSF a novel causal lncRNA for sow traits in QTLs. QTLs characterized at the genome‐wide level and identified 4,630 lncRNAs, with 13 differentially expressed during follicular atresia. , involved granulosa cell (sGC) function, as gene G to A transversion 128 nt its transcript shown be markedly associated traits. Mechanistically, after forming RNA:dsDNA triplexes promoter Caspase8 allele binds RNA‐binding protein (RBP) NR2C1 recruits induce transcription sGCs. Functionally, this leads loss inducing effect on sGC apoptosis by inactivating death receptor‐mediated apoptotic pathway. This study can used genetic improvement

Язык: Английский

Процитировано

1

Immunoinhibitory effects of hypoxia-driven reprogramming of EGR1hi and EGR3 positive B cells in the nasopharyngeal carcinoma microenvironment DOI
Yizhi Ge, Haitao Liu, Wenxuan Huang

и другие.

Oral Oncology, Год журнала: 2024, Номер 158, С. 106999 - 106999

Опубликована: Авг. 27, 2024

Язык: Английский

Процитировано

1

N6‐methyladenosine reader YTHDF3‐mediated zinc finger protein 41 inhibits hepatocellular carcinoma progression by transcriptional repression of Snail DOI Creative Commons
Xinxin Li, Mengzhen Han, He Zhu

и другие.

MedComm, Год журнала: 2024, Номер 5(11)

Опубликована: Окт. 28, 2024

Abstract Advanced metastasis of hepatocellular carcinoma (HCC) significantly contributes to high death rates among patients. The efficiency targeted therapies and chemotherapeutic agents shows individual variability. Therefore, there is no effective treatment for advanced HCC. Zinc finger proteins (ZFPs) are known be crucial in various tumors, especially on In our study, we verified that ZFP41 could suppress the progression HCC through vitro vivo experiments. During past years, N6‐methyladenine (m 6 A) regulation has also been increasingly reported To investigate whether regulated via m A methylation, results showed YTHDF3 bound mRNA degrade it. Subsequently, further elucidate function ZFP41, identified Snail, a well‐known oncogenic molecule, RNA‐seq. As canonical component epithelial‐to‐mesenchymal transition (EMT) pathway, Snail plays pivotal role critical marker tumor invasion metastasis. Our inhibit EMT pathway its transcriptional repression. conclusion, study revealed potential prognostic element patients with HCC, targeting might used translational clinical applications as promising therapeutic target.

Язык: Английский

Процитировано

1

Role of N6-methyladenosine methylation in nasopharyngeal carcinoma: current insights and future prospective DOI Creative Commons

YaYan Zhao,

Jie Li, Mei-Juan Dian

и другие.

Cell Death Discovery, Год журнала: 2024, Номер 10(1)

Опубликована: Дек. 18, 2024

Abstract Nasopharyngeal carcinoma (NPC) is a distinct type of head and neck squamous cell prevalent in Southern China, Southeast Asia, North Africa. Despite advances treatment options, the prognosis for advanced NPC remains poor, underscoring urgent need to explore its underlying mechanisms develop novel therapeutic strategies. Epigenetic alterations have been shown play key role progression. Recent studies indicate that dysregulation RNA modifications specifically affects tumor-related transcripts, influencing various oncogenic processes. This review provides comprehensive overview altered their regulators NPC, with focus on m 6 A regulatory mechanisms. We discuss how modification influences gene expression initiation progression at molecular level, analyzing impact cancer-related biological functions. Understanding these could reveal new biomarkers targets offering promising directions future research precision medicine.

Язык: Английский

Процитировано

1

RETRACTED: METTL14 Promotes Lipid Metabolism Reprogramming and Sustains Nasopharyngeal Carcinoma Progression via Enhancing m6A Modification of ANKRD22 mRNA DOI Creative Commons
Wei Xiong,

Lvyuan Li,

Qiling Tang

и другие.

Research Square (Research Square), Год журнала: 2024, Номер unknown

Опубликована: Янв. 25, 2024

Abstract The authors have requested that this preprint be removed from Research Square.

Язык: Английский

Процитировано

0